Education
About Us
Working with TipRanks
Follow Us
Brakewood Harold Eugene Insider Profile
4 Followers
Brakewood Harold Eugene, CBO at Immuneering, holds 3.90K shares in Immuneering (Ticker: IMRX). Most recently, Brakewood Harold Eugene Bought $3,900 shares of Immuneering on Mar 25, 2024 for an estimated value of 9.98K.
Brakewood Harold Eugene has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Brakewood Harold Eugene's holdings
Insider Roles
CBO
Roles that Brakewood Harold Eugene holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Brakewood Harold Eugene
Brakewood Harold Eugene's Trading History
List of latest transactions for each holding click on a transaction to see Brakewood Harold Eugene's performance on stock
You May Also Like
Brakewood Harold Eugene insider profile FAQ
What is the percentage of profitable transactions made by Brakewood Harold Eugene?
The percentage of profitable transactions made by Brakewood Harold Eugene is ―.
What is the average return per transaction made by Brakewood Harold Eugene?
The average return per transaction made by Brakewood Harold Eugene is ―.
What stocks does Brakewood Harold Eugene hold?
Brakewood Harold Eugene holds: IMRX stocks.
What was Brakewood Harold Eugene’s latest transaction?
Brakewood Harold Eugene latest transaction was an Informative Buy of $9.98K.
What was Brakewood Harold Eugene's most profitable transaction?
Brakewood Harold Eugene’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Brakewood Harold Eugene's role in Immuneering?
Brakewood Harold Eugene's role in Immuneering is CBO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.